Nu Skin Enterprises (NYSE:NUS) Given New $11.50 Price Target at Citigroup

Nu Skin Enterprises (NYSE:NUS) had its price objective reduced by analysts at Citigroup from $14.00 to $11.50 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Citigroup’s price objective would indicate a potential upside of 14.20% from the stock’s current price.

Separately, DA Davidson reduced their price objective on Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating on the stock in a research report on Thursday, May 9th. Four analysts have rated the stock with a hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.00.

Nu Skin Enterprises Price Performance

Nu Skin Enterprises stock traded down $0.33 during midday trading on Friday, reaching $10.07. The company’s stock had a trading volume of 918,117 shares, compared to its average volume of 748,592. Nu Skin Enterprises has a 52 week low of $9.74 and a 52 week high of $25.51. The company has a current ratio of 2.09, a quick ratio of 1.24 and a debt-to-equity ratio of 0.56. The business has a 50-day moving average price of $11.28 and a 200-day moving average price of $12.90. The stock has a market cap of $500.15 million, a PE ratio of -167.83 and a beta of 1.13.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.03. The company had revenue of $439.10 million for the quarter, compared to analyst estimates of $431.87 million. Nu Skin Enterprises had a negative net margin of 0.17% and a positive return on equity of 9.28%. The firm’s revenue was down 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.54 EPS. On average, sell-side analysts predict that Nu Skin Enterprises will post 1.1 EPS for the current year.

Insider Buying and Selling

In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $13.33, for a total transaction of $26,660.00. Following the sale, the director now owns 23,225 shares of the company’s stock, valued at $309,589.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Nu Skin Enterprises

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of Nu Skin Enterprises by 4.4% in the first quarter. Vanguard Group Inc. now owns 6,489,580 shares of the company’s stock valued at $89,751,000 after buying an additional 274,309 shares in the last quarter. Federated Hermes Inc. lifted its position in Nu Skin Enterprises by 111.8% in the 2nd quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock valued at $13,950,000 after acquiring an additional 698,722 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Nu Skin Enterprises by 17.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock valued at $22,482,000 after purchasing an additional 173,193 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Nu Skin Enterprises by 5.1% in the second quarter. Bank of New York Mellon Corp now owns 901,098 shares of the company’s stock valued at $9,498,000 after purchasing an additional 43,935 shares in the last quarter. Finally, ProShare Advisors LLC lifted its holdings in shares of Nu Skin Enterprises by 36.5% in the first quarter. ProShare Advisors LLC now owns 597,614 shares of the company’s stock valued at $8,265,000 after purchasing an additional 159,831 shares in the last quarter. Institutional investors own 82.84% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.